Table 4 Overall effect of treatment on the evolution eGFR, microvascular inflammation (MVI) and chronic transplant glomerulopathy (cg); Fisher’s exact test p = 0.64, 0.86 and 1.0, respectively
No treatment at the time of dnDSA (n = 9) | Any combination of treatment at the time of dnDSA (n = 13) | |
|---|---|---|
eGFR evolution | ||
○ eGFR increase | 3 | 4 |
○ Stable eGFR | 1 | 0 |
○ eGFR decrease | 5 | 9 |
MVI evolution | ||
○ MVI reduction | 3 | 6 |
○ No change in MVI | 3 | 4 |
○ MVI progression | 3 | 3 |
Cg evolution | ||
○ Cg reduction | 1 | 0 |
○ No change in cg | 5 | 11 |
○ Cg progression | 3 | 2 |